Abstract
A High Throughput Screening campaign allowed the identification of a novel class of ureas as 11β-HSD1 inhibitors. Rational chemical optimization provided potent and selective inhibitors of both human and murine 11β-HSD1 with an appropriate ADME profile and ex vivo activity in target tissues.
Copyright © 2011 Elsevier Ltd. All rights reserved.
MeSH terms
-
11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors*
-
11-beta-Hydroxysteroid Dehydrogenase Type 1 / metabolism
-
Administration, Oral
-
Animals
-
Binding Sites
-
Crystallography, X-Ray
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacokinetics
-
High-Throughput Screening Assays
-
Humans
-
Mice
-
Pyrazoles / chemistry*
-
Pyrrolidines / chemistry*
-
Urea / chemical synthesis
-
Urea / chemistry*
-
Urea / pharmacokinetics
Substances
-
Enzyme Inhibitors
-
Pyrazoles
-
Pyrrolidines
-
pyrazole
-
Urea
-
11-beta-Hydroxysteroid Dehydrogenase Type 1
-
pyrrolidine